Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
Nicklas J. Johansen, Thomas F. Dejgaard, Asger Lund, Camilla Schlüntz, Christian S. Frandsen, Julie Lyng Forman, Nicolai J. Wewer Albrechtsen, Jens J. Holst, Ulrik Pedersen‐Bjergaard, Sten Madsbad, Tina Vilsbøll, Henrik U. Andersen, Filip K. Knop
Topics & Concepts
MedicineExenatideType 2 diabetesPlaceboDouble blindDiabetes mellitusMealRandomized controlled trialInternal medicineEndocrinologyAlternative medicinePathologyDiabetes Treatment and ManagementDiabetes Management and ResearchPancreatic function and diabetes